Market Tracker

10/24 6:05pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

30.66
Data as of Oct 24
 -2.58 / -7.76%
Today’s Change
26.25
Today|||52-Week Range
101.00
-56.79%
Year-to-Date
No recent news for Aegerion Pharmaceuticals Inc.

Today’s Trading

Previous close33.24
Today’s open33.24
Day’s range30.40 - 33.54
Volume1,304,116
Average volume (3 months)1,075,299
Market cap$905.9M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+17.05%
Earnings growth (this year)+60.67%
Earnings growth (next 5 years)-236.49%
Revenue growth (last year)--
P/E ratioNM
Price/Sales42.22
Price/Book7.97

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...-0.36-2.95%
IMGNImmunoGen Inc-0.47-5.10%
FMIFoundation Medicine ...+1.71+7.43%
HALOHalozyme Therapeutic...-0.11-1.19%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$48.5M
Annual profit (last year)-$63.4M
Net profit margin-130.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc D. Beer
Chief Operating Officer
Craig E. Fraser
Corporate headquarters
Cambridge, Massachusetts

Forecasts